EA
NEO icon

Emerald Acquisition’s NeoGenomics NEO Stock Holding History

Emerald Acquisition’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$15.7M Buy
1,904,580
+273,278
+17% +$2.29M 0.03% 641
2016
Q2 		$13.1M Buy
+1,631,302
New +$13.1M 0.02% 796

Other funds holding NEO

GE
General Electric Evendale, Ohio $308M AUM 40.86% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Emerald Acquisition's NEO Position: Q3 2016 in Review

Emerald Acquisition increased its NeoGenomics (NEO) stake by 17% in Q3 2016, buying an estimated $2.29M and bringing the position to 1,904,580 shares worth $15.7M. The position accounts for 0.03% of the portfolio, ranked #641.

Emerald Acquisition first reported a position in NEO in Q2 2016 and has held it in 2 quarters since. 137 funds tracked by Wall St. Rank hold NEO as of Q3 2016.

  • Emerald Acquisition held 1,904,580 shares of NeoGenomics worth $15.7M as of Q3 2016.
  • Emerald Acquisition bought 273,278 NeoGenomics shares in Q3 2016, an estimated $2.29M.
  • NeoGenomics made up 0.03% of Emerald Acquisition's portfolio in Q3 2016, its #641 holding.
  • Emerald Acquisition first reported a position in NeoGenomics in Q2 2016 and has held it in 2 quarters since.
  • 137 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.